View in EDS HTML Full Text PDF Full Text

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.

Saved in:
Bibliographic Details
Title: Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.
Authors: van Kooten, Harmke A.1 (AUTHOR), Ditters, Imke A. M.2 (AUTHOR), Hoogeveen-Westerveld, Marianne3 (AUTHOR), Jacobs, Edwin H.3 (AUTHOR), van den Hout, Johanna M. P.2 (AUTHOR), van Doorn, Pieter A.1 (AUTHOR), Pijnappel, W. W. M. Pim3 (AUTHOR), van der Ploeg, Ans T.2 (AUTHOR), van der Beek, Nadine A. M. E.1,4 (AUTHOR) n.beek@erasmusmc.nl
Source: Orphanet Journal of Rare Diseases. 2/2/2022, Vol. 17 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17501172
DOI:10.1186/s13023-022-02175-2